Dyne Therapeutics, Inc. (DYN)
NASDAQ·Healthcare·Biotechnology
$18.16
+0.00%
Mkt Cap $3.23B
Analyst Ratings
Buy
9
Hold
0
Sell
1
Price Target (41 analysts)
$35.20
Range $24.00 – $50.00
Implied Upside
+93.9%
Consensus $35.20 vs current $18.16
NASDAQ·Healthcare·Biotechnology
$18.16
+0.00%
Mkt Cap $3.23B
Buy
9
Hold
0
Sell
1
Price Target (41 analysts)
$35.20
Range $24.00 – $50.00
+93.9%
Consensus $35.20 vs current $18.16